Status:
COMPLETED
Mapping Genes for Type 2 (Non-Insulin Dependent) Diabetes Mellitus
Lead Sponsor:
National Human Genome Research Institute (NHGRI)
Conditions:
Genetic Variation
Diabetes
Eligibility:
All Genders
1-65 years
Brief Summary
The aim of the project is to positionally clone susceptibility genes for NIDDM. Patients will be ascertained in Finland from previous health surveys and hospital discharge records. Approximately 400 a...
Detailed Description
The Finland-United States investigation of NIDDM (FUSION) study is a long-term effort to identify susceptibility genes for Type 2 diabetes (T2D) and associated quantitative traits. This involves the...
Eligibility Criteria
Inclusion
- No eligibility criteria listed.
Exclusion
Key Trial Info
Start Date :
June 1 1996
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 22 2020
Estimated Enrollment :
32379 Patients enrolled
Trial Details
Trial ID
NCT00339885
Start Date
June 1 1996
End Date
May 22 2020
Last Update
May 27 2020
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Natl Inst for Health & Welfare (THL)
Helsinki, Finland
2
Research Ethics Committee of Hospital District of Northern Savo
Kuopio, Finland
3
University of Tromso
Tromsø, Norway
4
Norwegian U of Science & Technology
Trondheim, Norway